Advertisement

HindustanTimes Sat,19 Apr 2014

Dr Reddy's launches generic Zoledronic Acid injection in US

PTI  New Delhi, April 04, 2013
First Published: 12:39 IST(4/4/2013) | Last Updated: 12:43 IST(4/4/2013)

Drug firm Dr Reddy's Laboratories on Thursday said it has launched generic Zoledronic Acid injection used for treating osteoporosis and Paget's disease of bone in the US market following approval from the US health regulator.

Advertisement

The company has launched Zoledronic Acid injection (5 mg/100 mL) on Wednesday, following approval of its abbreviated new drug application (ANDA) by the US Food & Drug Administration (USFDA), Dr Reddy's Laboratories said in a statement.

The product is generic version of Novartis AG's Reclast injection in the same strength, it added.

"The Reclast brand had total US sales of approximately USD 355 million for the most recent twelve months ending February, 2013 according to IMS Health," Dr Reddy's said.

The company's Zoledronic Acid injection is available in a single use vial for intravenous infusion, it added.

Paget's disease of bone is a chronic disorder that can result in enlarged and misshapen bones.

Shares of Dr Reddy's Laboratories were today trading at Rs. 1,888.60 apiece on the BSE in afternoon trade, up 2.93% from their previous close.

Advertisement
more from Business

700 trainees opt for exit plan at Nokia’s Chennai plant

Finnish handset maker Nokia, struggling to shepherd its Chennai plant into its agreement to be bought by US software giant Microsoft amid tax disputes in India, has got some success with 736 of its trainees accepting the voluntary separation scheme.
markets
Advertisement
Most Popular
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved